Combination effects of normobaric hyperoxia and edaravone on focal cerebral ischemia-induced neuronal damage in mice

Neuroscience Letters

Volumn 441, Issue 2, 2008, Pages 224-228

  Nonaka, Yuko ^a,b   Shimazawa, Masamitsu ^a   Yoshimura, Shinichi ^b   Iwama, Toru ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Combination therapy; Edaravone; Focal cerebral ischemia; Normobaric hyperoxia

Indexed keywords

HYDROXYL RADICAL; NORPHENAZONE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERBARIC OXYGEN; HYPEROXIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIPYRINE; BLOOD PRESSURE; CELL DEATH; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; HYPERBARIC OXYGENATION; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; NEUROLOGIC EXAMINATION; NEURONS; TETRAZOLIUM SALTS;

EID: 46749109125     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.06.033     Document Type: Article

References (19)

1. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters, Cerebrovasc. Dis. 15 (2003) 222-229.
2. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
3. Anderson D.C., Bottini A.G., Jagiella W.M., Westphal B., Ford S., Rockswold G.L., and Loewenson R.B. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke 22 (1991) 1137-1142
4. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2007-2012
5. Hara H., Huang P.L., Panahian N., Fishman M.C., and Moskowitz M.A. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16 (1996) 605-611
6. Higashi Y., Jitsuiki D., Chayama K., and Yoshizumi M. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases. Recent Patents Cardiovasc. Drug Discov. 1 (2006) 85-93
7. Imai K., Mori T., Izumoto H., Takabatake N., Kunieda T., and Watanabe M. Hyperbaric oxygen combined with intravenous edaravone for treatment of acute embolic stroke: a pilot clinical trial. Neurol. Med. Chir. (Tokyo) 46 (2006) 373-378
8. Kawai H., Nakai H., Suga M., Yuki S., Watanabe T., and Saito K.I. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281 (1997) 921-927
9. Kim H.Y., Singhal A.B., and Lo E.H. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann. Neurol. 57 (2005) 571-575
10. Kotani Y., Nakajima Y., Hasegawa T., Satoh M., Nagase H., Shimazawa M., Yoshimura S., Iwama T., and Hara H. Propofol exerts greater neuroprotection with disodium edetate than without it. J. Cereb. Blood Flow Metab. 28 (2008) 354-366
11. Narkowicz C.K., Vial J.H., and McCartney P.W. Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic. Res. Commun. 19 (1993) 71-80
12. Qi X., Okuma Y., Hosoi T., and Nomura Y. Edaravone protects against hypoxia/ischemia-induced endoplasmic reticulum dysfunction. J. Pharmacol. Exp. Ther. 311 (2004) 388-393
13. Shin H.K., Dunn A.K., Jones P.B., Boas D.A., Lo E.H., Moskowitz M.A., and Ayata C. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 130 (2007) 1631-1642
14. Singhal A.B., Benner T., Roccatagliata L., Koroshetz W.J., Schaefer P.W., Lo E.H., Buonanno F.S., Gonzalez R.G., and Sorensen A.G. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 36 (2005) 797-802
15. Singhal A.B., Dijkhuizen R.M., Rosen B.R., and Lo E.H. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 58 (2002) 945-952
16. Singhal A.B., Wang X., Sumii T., Mori T., and Lo E.H. Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 22 (2002) 861-868
17. Yang G., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., and Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25 (1994) 165-170
18. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225
19. Zhang W., Sato K., Hayashi T., Omori N., Nagano I., Kato S., Horiuchi S., and Abe K. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol. Res. 26 (2004) 342-348